LUMC collaborates with French therapy developer HORAMA to develop gene therapy for genetic eye disease
The Leiden University Medical Center (LUMC) has exclusively licensed its recently developed gene therapy program to treat Inherited Retinal Dystrophy to French therapy developer HORAMA for further clinical development.